Confusion and conflict versus provision and protection—which would you prefer? When we leave God out of our plans, we’re inviting all sorts of chaos into our lives, not to mention regret and loss. In this message, Dr. Stanley warns us against going our own way without a thought to what God thinks about our choices. God’s plans are the best plans, so why not partner with Him?
How do you obey when you don’t have the full picture? Learn from Noah. In this message, Dr. Stanley teaches us that, like Noah, we all have divine assignments. No matter what God calls us to do, our responsibility is to obey His instructions and trust Him to guide us. Discover the freedom in relying on God’s plan and not your own.
Candidates Generated with United Neuroscience Endobody Technology Will be Tested at the Center for Alzheimer’s and Neurodegenerative Diseases
DUBLIN, April 11, 2018 /PRNewswire/ — United Neuroscience, Ltd., (UNS), today announced that it has signed a collaboration agreement with the Center for Alzheimer’s and Neurodegenerative Diseases at the University of Texas Southwestern Medical Center to identify distinct pathogenic species of tau protein and evaluate promising therapeutic vaccine candidates to contribute to therapies for Alzheimer’s and other neurodegenerative diseases. As part of the collaboration, the Center for Alzheimer’s and Neurodegenerative Diseases will test United Neuroscience Endobody vaccine candidates using human postmortem tissue samples and preclinical models of neurodegenerative disease.
“We are committed to applying our Endobody technology in areas of great potential impact and working with researchers who are best positioned to accelerate development of therapeutics," stated Mei Mei Hu, chief executive officer of UNS. “It takes a many minds, a team, an ecosystem, to beat a disease as Alzheimer’s. Working with leading researchers as Marc Diamond at The Center for Alzheimer’s and Neurodegenerative Diseases at UT Southwestern will provide important data as we expand our clinical pipeline to include tau protein as a mechanistic target."